尼达尼布治疗的非特发性肺纤维化进行性纤维化间质性肺病患者的耐受性和总死亡率:来自单一专家中心的真实证据

{"title":"尼达尼布治疗的非特发性肺纤维化进行性纤维化间质性肺病患者的耐受性和总死亡率:来自单一专家中心的真实证据","authors":"P. Rivera Ortega, L. Stranks, K. Newman, T. Garfoot, H. Morris, K. Zakis, J. Swale, M. Greaves, S. Stanel, C. Avram, J. Blaikley, C. Hayton, C. Leonard","doi":"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1522","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":422056,"journal":{"name":"A39. MANAGEMENT OF INTERSTITIAL LUNG DISEASE AND ITS CO-MORBIDITIES","volume":"26 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Tolerability and Overall Mortality in Patients With Non-idiopathic Pulmonary Fibrosis Progressive Fibrosing Interstitial Lung Disease Treated With Nintedanib: Real-world Evidence From a Single Specialist Centre\",\"authors\":\"P. Rivera Ortega, L. Stranks, K. Newman, T. Garfoot, H. Morris, K. Zakis, J. Swale, M. Greaves, S. Stanel, C. Avram, J. Blaikley, C. Hayton, C. Leonard\",\"doi\":\"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1522\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":422056,\"journal\":{\"name\":\"A39. MANAGEMENT OF INTERSTITIAL LUNG DISEASE AND ITS CO-MORBIDITIES\",\"volume\":\"26 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"A39. MANAGEMENT OF INTERSTITIAL LUNG DISEASE AND ITS CO-MORBIDITIES\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1522\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"A39. MANAGEMENT OF INTERSTITIAL LUNG DISEASE AND ITS CO-MORBIDITIES","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1522","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}